Multiplexed Diagnostic can be used in lieu of conventional individual procedures to determine a large number of conditions in a single test

 

As part of the global evolution, the field of biotechnology has witnessed the adoption of multiplexed diagnostic technologies, which combine traditional microbial diversity detection with molecular biology approaches. These technologies enable the detection and rapid diagnosis of pathogenicity and antimicrobial resistance in a wide range of biological and non-bacterial infectious agents. The major beneficiaries of these technologies are the clinical management of patients with potentially serious health risks posed by pathogens, rapid identification of novel agents, and the prevention of the international spread of bacterial and viral diseases. These diagnostic technologies are rapidly replacing the use of culture and molecular probe-based techniques in several fields such as the field of infectious disease, food and chemical safety, pharmaceuticals, and public health. For instance, in October 2021, a multiplexed diagnostic solution provider company in the U.S., LexaGene Holdings, Inc., introduced the MiQLab™ system for testing pathogen resistance in veterinary diagnostics. Such systems are designed to help organizations gain a competitive edge through the enhanced visibility offered by real-time data, in response to requests from their patients.

In a number of industries across various applications and verticals, companies have started using multiplexed diagnostic solutions in order to gain a competitive advantage. The diagnostic test results can be easily shared across the organization through real-time communication interfaces like the internet or telecoms networks. The system used is normally a centralized solution that enables quick identification of problems in an application or a component and its subsequent repair using state-of-the-art tools and technologies.

The single-pass drug evolving diagnostic systems enable users to rapidly analyze a small set of biochemical parameters in real time, for a specified duration. They are typically used to evaluate on genetic modifications, abnormalities, or transcript abnormalities. A single-pass drug evolving diagnostic system enables users to run multiple experiments on a sample of cells in a very short time. They can be easily implemented in a number of different environments.